For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Injection of AAV2-REP1 | Injection of AAV-REP1, 1.00x10e11 vg, subretinal injection of total volume of 100 μL. Injection of AAV2-REP1 (10e11 vg): Single Group: single arm study | 0 | None | 0 | 6 | 6 | 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Cataract | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |
| Diplopia | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |
| Vitreous Cells | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |
| Anterior Chamber Cells | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |
| Extrafoveal macular retinal hole in area of nonfunctioning retina | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |
| Subretinal fluid | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |
| Conjunctiva hemorrhage, edema | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 21.1 | View |